A Large Rheumatoid Nodule Mimicking Hepatic Malignancy
Claudia Campani, Maria Guido, Stefano Colagrande, Francesca Bartoli, Umberto Arena, Fabio Marra – 8 September 2018
A Model to Predict 1‐Month Risk of Transplant or Death in Hepatitis A–Related Acute Liver Failure
Jin Dong Kim, Eun Ju Cho, Choonghyun Ahn, Sue K. Park, Jong Young Choi, Han Chu Lee, Do Young Kim, Moon Seok Choi, Hee Jung Wang, In Hee Kim, Jong Eun Yeon, Yeon Seok Seo, Won Young Tak, Moon Young Kim, Heon Ju Lee, Yun Soo Kim, Dae Won Jun, Joo Hyun Sohn, So Young Kwon, Sang Hoon Park, Jeong Heo, Sook‐Hyang Jeong, Jeong‐Hoon Lee, Nobuaki Nakayama, Satoshi Mochida, Akio Ido, Hirohito Tsubouchi, Hazime Takikawa, Shalimar, Subrat Kumar Acharya, William Bernal, John O’Grady, Yoon Jun Kim – 8 September 2018 – Acute liver failure (ALF) caused by hepatitis A is a rare but fatal disease.
LiverLearning®: 2018 Webinar: Implications of the Hepatitis C Epidemic on Women & Children
Chronic hepatitis C infection remains a major public health burden with substantial morbidity and mortality. In this program, expert hepatologists will provide a state-of-the-art update on the evolving epidemiology, natural history, and evidence-based management of hepatitis C infection in women of child-bearing age, pregnancy, and children.Dawn S. Harrison (Moderator) Dawn S. Harrison is a Family Nurse Practitioner specializing in Gastroenterology and Hepatology at The University of North Carolina Medical Center, Chapel Hill, North Carolina.
The Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Outcomes
Carrie R. Wong, Joseph K. Lim – 7 September 2018
Dipeptidyl Peptidase‐4 Is a Pro‐Recovery Mediator During Acute Hepatotoxic Damage and Mirrors Severe Shifts in Kupffer Cells
Nádia Duarte, Inês Coelho, Denys Holovanchuk, Joana Inês Almeida, Carlos Penha‐Gonçalves, Maria Paula Macedo – 7 September 2018 – Dipeptidyl peptidase‐4 (DPP‐4 or clusters of differentiation [CD]26) is a multifunctional molecule with established roles in metabolism. Pharmacologic inhibition of DPP‐4 is widely used to improve glycemic control through regulation of the incretin effect. Colaterally, CD26/DPP‐4 inhibition appears to be beneficial in many inflammatory conditions, namely in delaying progression of liver pathology.
Geographic Areas of Liver Distribution in the United States Should Not Be Redesigned According to the 2016 Eight‐District Organ Procurement and Transplantation Network Proposal
Jennifer Batisti, Emily A. Schonfeld, Clara Tow, Robert S. Brown – 7 September 2018
PRO: Redistricting of United Network for Organ Sharing Regions to Improve Geographic Disparities in Liver Transplantation
Fernando H. Calmet, Maria Samuel, Paul Martin – 7 September 2018
High‐Mobility Group Box‐1 and Liver Disease
Harriet Gaskell, Xiaodong Ge, Natalia Nieto – 7 September 2018 – High‐mobility group box‐1 (HMGB1) is a ubiquitous protein. While initially thought to be simply an architectural protein due to its DNA‐binding ability, evidence from the last decade suggests that HMGB1 is a key protein participating in the pathogenesis of acute liver injury and chronic liver disease.
Closing the Quality Chasm in Cirrhosis
Kai Rou Tey, Prashanthinie Mohan, Xibei Liu, Archita P. Desai – 7 September 2018
Pitfalls in Gd‐EOB‐DTPA–Enhanced Liver Magnetic Resonance Imaging With an Emphasis on Nontumorous Lesions
Yedaun Lee, So Yeon Kim, Seung Soo Lee, Seong Ho Park, Kyoung Won Kim, Jae Ho Byun, Moon‐Gyu Lee – 7 September 2018